n.— «A biosimilar is defined as a biopharmaceutical product—i.e. a drug with a protein as an active ingredient which is produced by genetically modified cell lines which, despite different producing cell lines, compared to an initial supplier product which is already on the market, is so similar that the biosimilar has proven therapeutic equivalence.» —“STADA reorganizes Biosimilar projects—Epo-zeta distribution” Ad-Hoc-News (Germany) Nov. 20, 2006. (source: Double-Tongued Dictionary)

Tagged with →  

This site uses Akismet to reduce spam. Learn how your comment data is processed.